MSD has only just completed its $10 billion takeover of Verona Pharma, but is still on the hunt for more bolt-on acquisitions to flesh out its pipeline, according to chief executive Rob Davis. On the ...
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
You're hunched over the engine with your wrist painfully contorted, wishing you were Mr. Fantastic. You've finally removed broken spark plug number four and then the intrusive thought hits. "Should I ...
Winter is stranding drivers across the U.S. and Europe as freezing temps kill car batteries overnight. But one unlikely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results